SynthesisThe Cochrane database of systematic reviews2002
Antidepressants for smoking cessation.
Synthesis in The Cochrane database of systematic reviews, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2020Pooled it
- Antidepressants for smoking cessation.The Cochrane database of systematic reviews · 2014Pooled it
- Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.BMC public health · 2006Pooled it
- The inclusion of women and minorities in smoking cessation clinical trials: a systematic review.The American journal on addictionsPooled it
- Bupropion SR for the treatment of smokeless tobacco use.Drug and alcohol dependence · 2007Trial
- Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2007Trial
- A randomised controlled trial of motivational interviewing for smoking cessation.The British journal of general practice : the journal of the Royal College of General Practitioners · 2006Trial
- Research Trends on Smoking, Depression, and Anxiety: Bibliometric Analysis.Consortium psychiatricum · 2025Review
- Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis.BMC family practice · 2015Article
- Prospective cohort study of the effectiveness of smoking cessation treatments used in the "real world".Mayo Clinic proceedings · 2014Observational
- An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.Psychopharmacology · 2014Review
- Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Harm reduction journal · 2009Article
- Genetics of nicotine dependence and pharmacotherapy.Biochemical pharmacology · 2008Review
- A research agenda for assessing the potential contribution of genomic medicine to tobacco control.Tobacco control · 2007Article
- Review
- Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.Alcohol and alcoholism (Oxford, Oxfordshire)Review
Corrections and comments
- Updated by
- Update of
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are two reasons to believe antidepressants might help in smoking cessation. First, depression may be a symptom of nicotine withdrawal, and smoking cessation sometimes precipitates depression. Second, nicotine may have antidepressant effects that maintain smoking for some smokers. Antidepressants may substitute for this effect.
objectivesThe aim of this review is to assess the effectiveness of antidepressant medications in aiding long term smoking cessation. The drugs include bupropion; doxepin; fluoxetine; imipramine; moclobemide; nortriptyline; paroxetine; selegiline; sertraline, tryptophan and venlafaxine. SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction Group trials register which includes trials indexed in MEDLINE, EMBASE, SciSearch and PsycLIT, and other reviews and meeting abstracts, in September 2001. SELECTION CRITERIA: We considered randomized trials comparing antidepressant drugs to placebo or an alternative therapeutic control for smoking cessation. We excluded trials with less than 6 months follow-up. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate on the type of study population, the nature of the drug therapy, the outcome measures, method of randomisation, and completeness of follow-up. The main outcome measure was abstinence from smoking after at least six months follow-up in patients smoking at baseline. We used the most rigorous definition of abstinence for each trial, and biochemically validated rates if available. Where appropriate, we performed meta-analysis using a fixed effects model. MAIN
resultsThere was one trial each of moclobemide, sertraline and venlafaxine, two of fluoxetine and nortriptyline, and five trials of bupropion, one of which tested long term use to prevent relapse. Nortriptyline and bupropion both increased cessation. In one trial the combination of bupropion and nicotine patch produced slightly higher quit rates than patch alone. REVIEWER'S
conclusionsSome antidepressants (bupropion and nortriptyline) can aid smoking cessation. It is not clear whether these effects are specific for individual drugs, or would occur with any antidepressant.
Indexed as
Identifiers
11869562What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.